Riskpilot← Back to searchSign inGet full accessNEUROWAVE AS
ASActiveOrg 912604306Skogveien 6C, 1446 DrøbakEngineering activities and related technical consultancy · NACE 7112Est. 20130 employees
Revenue 2024
NOK 20K
-84% vs 2023
EBITDA margin
-23.6%
-104% vs 2023
Equity ratio
-106.4%
Financial strength
Net profit 2024
NOK -256K
+2% vs 2023
| Revenue | NOK 20K | -84% |
| EBITDA | NOK -5K | -104% |
| Net profit | NOK -256K | +2% |
| Total assets | NOK 493K | -43% |
| Equity | NOK -525K | -95% |
| Employees | 0 | — |
Legal name
NEUROWAVE AS
Org number
912604306
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
19. oktober 2013
Share capital
NOK 153 846
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Tilvirke og selge helserelaterte produkter, yte konsulentbistand i forbindelse med salg, og å investere i andre selskaper.
Address
Skogveien 6C, 1446 Drøbak
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 67 | 639 | 525 | 582 | 512 | 279 | 416 | 167 | 139 | 124 | 20 |
| Staff expenses | −0 | −0 | −1 | −0 | −0 | −1 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −11 | 13 | 288 | −267 | −644 | −198 | −253 | 241 | 108 | 136 | 127 | −5 |
| Depreciation & amort. | −0 | −0 | −315 | −316 | −346 | −382 | −430 | −425 | −407 | −360 | −342 | −245 |
| EBIT | −11 | 13 | −27 | −583 | −990 | −580 | −683 | −184 | −299 | −225 | −215 | −250 |
| Net financials | 0 | −8 | −34 | −34 | 106 | 11 | −39 | −42 | −16 | −46 | −47 | −0 |
| Profit before tax | −11 | 4 | −61 | −617 | −883 | −570 | −722 | −226 | −314 | −270 | −262 | −250 |
| Tax | −6 | 1 | −14 | −154 | 7 | 165 | −0 | −0 | −0 | −0 | −0 | 6 |
| Net profit | −6 | 3 | −47 | −464 | −890 | −734 | −722 | −226 | −314 | −270 | −262 | −256 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 15 | 2 950 | 3 272 | 3 304 | 4 062 | 3 231 | 2 623 | 2 074 | 1 577 | 1 210 | 862 | 493 |
| Equity | 15 | 18 | −29 | −493 | −746 | −1 481 | −2 203 | −2 428 | −2 742 | −3 013 | −269 | −525 |
| Long-term debt | 0 | 650 | 800 | 700 | 600 | 500 | 500 | 300 | 200 | 100 | 0 | 6 |
| Short-term debt | 0 | 2 283 | 2 501 | 3 097 | 4 208 | 4 211 | 4 325 | 4 202 | 4 119 | 4 122 | 1 130 | 1 012 |
| Total debt | 0 | 2 933 | 3 301 | 3 797 | 4 808 | 4 711 | 4 825 | 4 502 | 4 319 | 4 222 | 1 130 | 1 018 |
EBITDA margin
-23.6%
This company
15.8%
Market median
-249% vs market
20132024
Equity ratio
-106.4%
This company
38.2%
Market median
-379% vs market
20132024
Return on equity
-25612800.0%
This company
18.4%
Market median
-139200100% vs market
20132024
Net profit margin
-1277.0%
This company
8.1%
Market median
-15865% vs market
20132024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20132024
Debt / equity
1.94×
This company
0.62×
Market median
-213% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-10-16 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PR Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Hexagon Invest As | Company | 50.0% | 50.0% | 2022 |
Ranes Consulting As | Company | 50.0% | 50.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hexagon Invest As
NEUROWAVE AS Board members of NEUROWAVE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peder Ragnvald Køltzow | Chief Executive Officer | 0 companies |
| Lars Ranes | Chairman | 0 companies |